The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

被引：0
|
作者：
Kongju Wu
Ming Yi
Shuang Qin
Qian Chu
Xinhua Zheng
Kongming Wu
机构：
[1] Medical School of Pingdingshan University,Department of Clinical Medicine
[2] Huazhong University of Science and Technology,Department of Oncology, Tongji Hospital of Tongji Medical College
来源：
Experimental Hematology & Oncology | / 8卷
关键词：
Immunotherapy; PD-1; PD-L1; CTLA-4; Immune checkpoint inhibitor; Combination therapy; Meta-analysis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
    Wu, Kongju
    Yi, Ming
    Qin, Shuang
    Chu, Qian
    Zheng, Xinhua
    Wu, Kongming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [2] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis
    Jin, Chunhui
    Zhu, Xiaodan
    Huang, Xiaona
    Gong, Tingjie
    Wei, Zhipeng
    You, Jianliang
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (03) : 203 - 212
  • [3] Efficacy of PD-1/PD-L1 plus CTLA-4 inhibitors in solid tumors based on clinical characteristics: a meta-analysis
    Huo, Gengwei
    Liu, Wenjie
    Zhang, Sipei
    Chen, Peng
    IMMUNOTHERAPY, 2023, 15 (03) : 189 - 207
  • [4] Efficacy and safety of CTLA-4 inhibitors combined with PD-1 inhibitors or chemotherapy in patients with advanced melanoma
    Zhang, Bo
    Zhou, You Lang
    Chen, Xinming
    Wang, Ziheng
    Wang, Qiuhong
    Ju, Fei
    Ren, Shiqi
    Xu, Ran
    Xue, Qun
    Wu, Qiong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 68 : 131 - 136
  • [5] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis
    Song, Dandan
    Hou, Shufu
    Ma, Ning
    Yan, Bing
    Gao, Jing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis
    He, Runzhi
    Zhao, Xiaoling
    Liu, Jianmin
    Zhou, Yajing
    Zhang, Xiaochong
    Cheng, Fang
    MEDICINE, 2022, 101 (41) : E30561
  • [7] Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
    Xu, Li
    Yan, Xin
    Ding, Weiyue
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis
    Huang, Shuang
    Zheng, Gang
    Yang, Kai
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [9] Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis
    Shuang Huang
    Gang Zheng
    Kai Yang
    World Journal of Surgical Oncology, 21
  • [10] Correlation between sex and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors)
    Wu, Yingcheng
    Ju, Qianqian
    Jia, Keren
    Yu, Jingyan
    Shi, Hui
    Wu, Huiqun
    Jiang, Maorong
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (01) : 45 - 51
12345